Hem › Alzheimers sjukdom › Oklahoma
Kliniska studier för Alzheimers sjukdom i Oklahoma
6 studier för Alzheimers sjukdom söker deltagare vid platser i Oklahoma.
Städer i Oklahoma
Officiell studietext (engelska)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1640, Tulsa
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- The Rivus Wellness & Research Institute, Oklahoma City
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06585787A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Central States Research, Tulsa
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07011732Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0089, Ardmore
RekryterarFas 2
Ålder 55 till 90 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06808984Using Light Therapy for Mild Cognitive Impairment
- University of Oklahoma Health Campus, Oklahoma City
Rekryterar
Ålder 55 till 95 · Alla kön · Uppdaterad 16 juni 2026 · NCT07651787Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Oklahoma City
RekryterarFas 2
Ålder 50 till 85 · Alla kön · Uppdaterad 2 feb. 2026 · NCT07105709Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.